Abstract
Micron-sized bubbles of gas have been used commercially as contrast agents for ultrasound (US) for over 30 years. Recently interest has increased in combing the diagnostic imaging qualities of microbubbles (MBs) with drug delivery technology to produce new treatments for cancer. We have demonstrated a microfluidic device for producing drug-loaded MBs at high, clinically relevant concentrations (109 MB / mL) within 10 minutes. Currently, we report the potential for delivery of hydrophobic drugs by incorporating oil structures within the MB shell or attachment to the MB surface and in addition, an improvement in in vitro MB lifetime from 1 hour to over 5 hours at 37°C.
| Original language | English |
|---|---|
| Title of host publication | 17th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2013 |
| Publisher | Chemical and Biological Microsystems Society |
| Pages | 521-523 |
| Number of pages | 3 |
| ISBN (Print) | 9781632666246 |
| Publication status | Published - 2013 |
| Event | 17th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2013 - Freiburg, Germany Duration: 27 Oct 2013 → 31 Oct 2013 |
Conference
| Conference | 17th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2013 |
|---|---|
| Abbreviated title | MicroTAS 2013 |
| Country/Territory | Germany |
| City | Freiburg |
| Period | 27/10/13 → 31/10/13 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Drug delivery
- Hydrophobic delivery
- Microbubbles
ASJC Scopus subject areas
- Bioengineering
Fingerprint
Dive into the research topics of 'High production rates of stable drug-loadable microbubbles toward targetted, triggared drug delivery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver